Medtronic posted better-than-expected earnings, lifted its sales forecast, and faces analyst debate on growth prospects and possible divestitures.
Latest Ratings for MDT
DateFirmActionFromTo Feb 2022Credit SuisseMaintainsOutperform Feb 2022NeedhamMaintainsBuy Feb 2022Raymond JamesMaintainsOutperform